Adam E. Snook

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma”.

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma

Nature Communications(2022)10.1038/s41467-022-28801-y

N/A

2.1DataRank · unranked

100 citations

Timothy J. Purwin, McKenna Q. Glasheen, Signe Caksa, Manoela Tiago, Nicole A. Wilski +17 more

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001046

N/A

0.970DataRank · unranked

38 citations

Jagmohan Singh, Robert D. Carlson, Elinor Leong, Trevor R. Baybutt, Joshua R. Barton +9 more

Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential

Expert Opinion on Therapeutic Targets(2021)10.1080/14728222.2021.1937124

N/A

0DataRank · unranked

18 citations

Adam E. Snook, Scott A. Waldman, Ariana A. Entezari

GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer

Expert Review of Precision Medicine and Drug Development(2021)10.1080/23808993.2021.1876518

N/A

0DataRank · unranked

16 citations

John C. Flickinger, Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher +3 more

Stem Cells as Therapeutic Targets in Colorectal Cancer

Personalized Medicine(2021)10.2217/pme-2020-0099

N/A

0DataRank · unranked

14 citations

Adam E. Snook, Scott A. Waldman, Alicja Zalewski

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.12.014

N/A

0DataRank · unranked

12 citations

Ariana A. Entezari, Adi Caspi, Signe Caksa, Aakash Jhaveri, Timothy J. Stanek +8 more

The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission

Expert Opinion on Biological Therapy(2021)10.1080/14712598.2021.1929167

N/A

0DataRank · unranked

8 citations

Madison Crutcher, Scott A. Waldman, Adam E. Snook, Jessica Kopenhaver

Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers

Biomarkers in Medicine(2021)10.2217/bmm-2020-0654

N/A

0DataRank · unranked

7 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

Functional Assessment of Missense Variants in the ABCC6 Gene Implicated in Pseudoxanthoma Elasticum, a Heritable Ectopic Mineralization Disorder

Journal of Investigative Dermatology(2021)10.1016/j.jid.2021.08.435

N/A

0DataRank · unranked

4 citations

Jianhe Huang, Hongbin Luo, Jagmohan Singh, Adam E. Snook, Jouni Uitto +2 more

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy

npj Vaccines(2022)10.1038/s41541-022-00483-z

N/A

0DataRank · unranked

16 citations

Ross E. Staudt, Jagmohan Singh, Robert D. Carlson, Joshua R. Barton, Trevor R. Baybutt +6 more

Intestinal neuropod cell GUCY2C regulates visceral pain

Journal of Clinical Investigation(2022)10.1172/jci165578

N/A

0DataRank · unranked

24 citations

Annie K. Londregran, Tyler D. Alexander, Ariana A. Entezari, Shely Bar-Ad, Lan Cheng +5 more

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2033057

N/A

0DataRank · unranked

20 citations

Robert D. Carlson, Adam E. Snook, Ross E. Staudt

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C

Frontiers in Immunology(2022)10.3389/fimmu.2022.855759

N/A

0DataRank · unranked

18 citations

Jagmohan Singh, Yanki Yarman, Robert D. Carlson, Joshua R. Barton, Scott A. Waldman +2 more

Emerging drug targets for colon cancer: A preclinical assessment

Expert Opinion on Therapeutic Targets(2022)10.1080/14728222.2022.2039119

N/A

0DataRank · unranked

14 citations

Trevor R. Baybutt, Jessica Kopenhaver, Adam E. Snook, Scott A. Waldman, Madison Crutcher

Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer

Personalized Medicine(2022)10.2217/pme-2022-0026

N/A

0DataRank · unranked

7 citations

Ariana A. Entezari, Madison Crutcher, Adam E. Snook, Scott A. Waldman, Adi Caspi

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients

Expert Review of Clinical Pharmacology(2022)10.1080/17512433.2022.2138339

N/A

0DataRank · unranked

1 citations

Adam E. Snook, Scott A. Waldman, Madison Crutcher

IL‐8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR‐146a mediated mechanism

Molecular Carcinogenesis(2023)10.1002/mc.23587

N/A

0DataRank · unranked

11 citations

Alyssa N. Calder, Joseph P Flemming, Yiyang Guo, S. Gilmore, Melissa A. Trofa +20 more

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

Research Square(2023)10.21203/rs.3.rs-3416338/v1

N/A

0DataRank · unranked

1 citations

Lara Cheslow, Matthew Byrne, Jessica Kopenhaver, Lorraine Iacovitti, Richard J. Smeyne +2 more

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Science Immunology(2024)10.1126/sciimmunol.adn6509

N/A

0DataRank · unranked

48 citations

Guido Ghilardi, Yunlin Zhang, Yi‐Hao Chiang, Wei Xie, Puneeth Guruprasad +46 more

Biomarkers for Managing Neurodegenerative Diseases

Biomolecules(2024)10.3390/biom14040398

N/A

0DataRank · unranked

22 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy

Cancer Biology & Therapy(2024)10.1080/15384047.2024.2398801

N/A

0DataRank · unranked

9 citations

Ariana A. Entezari, Adi Caspi, Ross E. Staudt, Robert D. Carlson, Scott A. Waldman +2 more

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

npj Parkinson s Disease(2024)10.1038/s41531-024-00697-z

N/A

0DataRank · unranked

7 citations

Matthew Byrne, Jessica Kopenhaver, Lorraine Iacovitti, Richard J. Smeyne, Adam E. Snook +2 more

Biomarkers for Managing Neurodegenerative Diseases

The Medicine Forum(2024)10.20944/preprints202403.0247.v1

N/A

0DataRank · unranked

11 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer

Cancers(2025)10.3390/cancers17142356

N/A

0DataRank · unranked

3 citations

Ali Raza Shaikh, Zhengyang Sun, Babar Bashir, Adam E. Snook, Matthew D. Bloom

Immunotherapy for precision medicine in colorectal cancer

Expert Review of Precision Medicine and Drug Development(2025)10.1080/23808993.2025.2560303

N/A

0DataRank · unranked

2 citations

Michael Xu, Zinah A Bairmani, Babar Bashir, Scott A. Waldman, Adam E. Snook +1 more

Universal solid tumor therapy with CD5-deleted, DSG2-directed CAR-T cells.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2539

N/A

0DataRank · unranked

0 citations

Lindsay Weil, Trevor R. Baybutt, Ozlem Kulak, Miao Cao, Ross E. Staudt +15 more

122 Guanylyl cyclase C as a target for CAR-T cell therapy in a metastatic gastric cancer model

Regular and Young Investigator Award Abstracts(2020)10.1136/jitc-2020-sitc2020.0122

N/A

0DataRank · unranked

2 citations

Trevor R. Baybutt, Megan Weindorfer, Robert D. Carlson, Alicja Zalewski, Scott A. Waldman +2 more